aTYR PHARMA ATYR
NASDAQ ATYR
$0.38 +0.01 (+4.13%)
As of: Sep 21, 2026 · 10:48 AM EDT

aTYR PHARMA (ATYR) Treasury Shares (2014 - 2015)

aTYR PHARMA's (ATYR) quarterly Treasury Shares came in at $141.7 million in Q1 2015, up 92.76% quarter-over-quarter from $73.5 million in Q4 2014.

Analysis

aTYR PHARMA (ATYR) Treasury Shares (2014 - 2015) Analysis & Trends

aTYR PHARMA (ATYR) has reported Treasury Shares for 2 consecutive years, with $141.7 million the latest figure, recorded in Q1 2015.

  • For the quarter ending Q1 2015, Treasury Shares changed N/A year-over-year to $141.7 million; the trailing twelve-month figure through Mar 2015 stood at $141.7 million (changed N/A YoY), and the FY2014 full-year result was $73.5 million, changed 0.0% from the prior year.
  • Treasury Shares grew to $141.7 million in Q1 2015 per ATYR's latest filing, from $73.5 million in the prior quarter.
  • Across five years, Treasury Shares topped out at $141.7 million in Q1 2015 and bottomed at $73.5 million in Q4 2014.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Treasury Shares (Qtr)
1 Amgen 208.48 Bn 194.49 Bn 7.24 Bn -
2 Gilead Sciences 186.29 Bn 183.02 Bn 6.22 Bn -
3 Vertex Pharmaceuticals 128.79 Bn 120.93 Bn 2.84 Bn -
4 Regeneron Pharmaceuticals 80.66 Bn 72.67 Bn 3.93 Bn 36.40 Mn
5 Moderna 61.46 Bn 56.32 Bn 52.00 Mn -
6 Argenx Se 61.28 Bn 56.10 Bn 1.37 Bn -
7 Alnylam Pharmaceuticals 32.04 Bn 28.73 Bn 992.69 Mn -
8 Biogen 31.84 Bn 30.56 Bn 1.96 Bn -23.80 Mn
9 Roivant Sciences 28.74 Bn 29.43 Bn 1.16 Mn -
10 aTYR PHARMA 35.31 Mn -22.30 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2015 141.65 Mn
Mar 31, 2015 141.65 Mn
Dec 31, 2014 73.49 Mn
Dec 31, 2014 73.49 Mn